Borosil Scientific Ltd
BOROSCIBorosil Scientific Ltd
BOROSCI
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 56.73 | 4.35 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Borosil Scientific Ltd manufactures laboratory glassware and equipment, serving various sectors including pharmaceuticals, food testing, and microbiology with a wide range of products.
Peers
Compare with peersPoly Medicure Ltd
Tarsons Products Ltd
PREVEST DENPRO LTD
Balaxi Pharmaceuticals Ltd
Universus Photo Imagings Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2024 | TTM | ||
|---|---|---|---|---|
| Total Revenue | 400.00 | 428.84 | ||
Raw Materials | 143.97 | 366.51 | ||
| Power & Fuel Cost | 22.30 | |||
| Employee Cost | 75.24 | |||
| Selling & Administrative Expenses | 51.62 | |||
| Operating & Other expenses | 56.18 | |||
EBITDA | 50.69 | 62.33 | ||
| Depreciation/Amortization | 16.45 | 18.15 | ||
| PBIT | 34.24 | 44.18 | ||
| Interest & Other Items | 2.70 | 1.97 | ||
| PBT | 31.54 | 42.21 | ||
| Taxes & Other Items | 7.99 | 13.38 | ||
| Net Income | 23.55 | 28.83 | ||
| EPS | 2.65 | 3.25 | ||
| DPS | 0.00 | 0.00 | ||
| Payout ratio | 0.00 | 0.00 |
Company Updates
Annual report
PDFPeers & Comparison
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Borosil Scientific Ltd | 69.45 | 4.35 | — |
| Poly Medicure Ltd | 116.46 | 20.46 | 0.10% |
| Tarsons Products Ltd | 53.78 | 3.74 | 0.46% |
| PREVEST DENPRO LTD | 42.01 | 7.65 | 0.18% |
Price Comparison
Compare BOROSCI with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
May 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
BOROSCI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeBorosil Scientific has allotted 16,879 equity shares under ESOP on 26 November 2024. Pursuant to the aforesaid allotment of equity shares, the issued and paid up equity share capital of the Company stands increased to Rs. 8,88,97,082 divided into 8,88,97,082 equity shares of Re 1 each. Powered by Capital Market - Live
Net profit of Borosil Scientific declined 0.65% to Rs 7.69 crore in the quarter ended September 2024 as against Rs 7.74 crore during the previous quarter ended September 2023. Sales rose 3.19% to Rs 87.04 crore in the quarter ended September 2024 as against Rs 84.35 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales87.0484.35 3 OPM %15.3014.81 - PBDT15.0513.57 11 PBT10.8210.07 7 NP7.697.74 -1 Powered by Capital Market - Live
Borosil Scientific will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
Borosil Scientific has allotted 18,020 equity shares under ESOP on 16 October 2024. With this allotment, the paid up equity share capital has increased to Rs. 8,88,80,203 divided into 8,88,80,203 equity shares of Re 1 each. Powered by Capital Market - Live
Net profit of Borosil Scientific rose 54.05% to Rs 6.47 crore in the quarter ended June 2024 as against Rs 4.20 crore during the previous quarter ended June 2023. Sales rose 17.17% to Rs 93.40 crore in the quarter ended June 2024 as against Rs 79.71 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales93.4079.71 17 OPM %11.737.88 - PBDT12.867.02 83 PBT8.663.65 137 NP6.474.20 54 Powered by Capital Market - Live
Borosil Scientific announced that the Annual General Meeting (AGM) of the company will be held on 3 September 2024.Powered by Capital Market - Live
Borosil Scientific will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant